HealthDay News — Gender-affirming hormone therapy (GAHT) in primary care is associated with lower rates of moderate-to-severe depressive symptoms in US transgender, nonbinary, and gender-diverse (TGD) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback